Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
Recruiting
N/A
Interventional Study
SARS CoV-2
Kawasaki Disease
Retrovirus Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 120 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Human Endogenous Retroviruses (HERVs) are ancient sequences that became integrated into our DNA during evolutionary processes.
The significance of their presence in DNA is still being studied, but HERVs appear to be involved in the regulation of the immune response.
The gut microbiota is the set of microorganisms that physiologically colonize the gastrointestinal tract. Progressively increasing …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pediatric patients, newly diagnosed with Kawasaki disease
* Pediatric patients, newly diagnosed with Vasculitis
* Pediatric patients, newly diagnosed with SARS-CoV-2 infection
* Pediatric patients, newly diagnosed with febrile virosis
* Pediatric patients with inflammatory dis…
Contacts